CA
NZ
UK
AU
IND
US
Boston Scientific Corporation (NYSE: BSX) is a leading global medical technology company that develops and manufactures innovative devices for cardiovascular, electrophysiology, structural heart, peripheral interventions, endoscopy, urology, neuromodulation, and interventional oncology markets. The company generates revenue through the commercialization of advanced medical devices and minimally invasive therapies, supported by continuous product innovation, strategic acquisitions, and a broad global distribution network serving hospitals, physicians, and healthcare providers worldwide.
As per US The Shariah Compliance Report published on ‘BSX’ on Jul 10, 2026, Kalkine provided an ‘Buy’ stance on the stock at USD 45.01 based on technical analysis and the stock price has now moved up by ~ 14.26% since then and attained resistance 1 and moving towards resistance 2.
Noted below are the details of support and resistance levels provided in our previous report:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...